Skip to main content
. 2017 May 11;8(31):51478–51491. doi: 10.18632/oncotarget.17807

Figure 1. Characteristic of cell viability and ROS levels following different treatment in HCT116, HCT-8/5-FU or NCM460 cells.

Figure 1

(A-C) Characteristic of cell viability treated by single or combined treatment of 5-FU, DTN or DHA in HCT116 cells (A), HCT-8/5-FU cells (B) and NCM460 cells (C) were determined by MTT assay. (D) Characteristic of ROS levels following different treatment for 24 h in HCT116 and HCT-8/5-FU cells were determined by DCFH-DA assays. *P <0.05 showed a significant difference compared to control group.